PRESENTATION TITLE

Genomics England's Cancer Research and Precision Medicine Programs

PRESENTER(S)

Professor Matthew A. Brown, Chief Scientific Officer Genomics England, Professor of Medicine, Kings College, London

PRESENTER BIO

Professor Matthew Brown, is an internationally renowned clinician-scientist, and Director of the National Institute for Health Research (NIHR) Guy’s and St Thomas’ Biomedical Research Centre (BRC) and Professor of Medicine within the Faculty of Life Sciences & Medicine. He joined King’s as Professor of Medicine and to lead the BRC, which aims to transform scientific breakthroughs into life-saving treatments for patients.

Professor Brown trained as a clinician-scientist and a rheumatologist, including a period of post-graduate study at the University of Oxford. He has made contributions to the development of gene-mapping approaches in human diseases and genome-wide association study methodology, leading to the discovery of thousands of genetic variants, with a particular interest in ankylosing spondylitis, rheumatoid arthritis, and osteoporosis. In the genetics of rare human diseases, he has identified genes responsible for monogenic forms of arthritis, ectopic bone development, and skeletal dysplasias. He has also led efforts in Australia to translate research sequencing capability into precision medicine programs for cancer patients. He was elected Fellow of the Australian Academy of Science in 2013, and Fellow of the Australian Academy of Health and Medical Sciences in 2015.

His team at King's College London are focussing on the immunogenetics of ankylosing spondylitis, and on developing novel therapies informed by these studies. They research the role of the microbiome in the disease, and its potential as a therapeutic target. They are also studying novel biomarkers and their utility for diagnosis and prognosis prediction in axial spondyloarthritis (non-radiographic axial spondyloarthritis and ankylosing spondylitis). In addition to research in ankylosing spondylitis, Professor Brown is coordinating national collaborative programs in research in polygenic risk scores as clinical tools.

VIEWING LOCATIONS
Zoom Registration Link

LEARNING OBJECTIVES

• Review the utility of Genomic England's research assets for cancer research and personalized medicine.
• Describe examples of key findings demonstrating the power of these datasets.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.